Three postpartum antiretroviral regimens to prevent intrapartum HIV infection
- PMID: 22716975
- PMCID: PMC3590113
- DOI: 10.1056/NEJMoa1108275
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection
Abstract
Background: The safety and efficacy of adding antiretroviral drugs to standard zidovudine prophylaxis in infants of mothers with human immunodeficiency virus (HIV) infection who did not receive antenatal antiretroviral therapy (ART) because of late identification are unclear. We evaluated three ART regimens in such infants.
Methods: Within 48 hours after their birth, we randomly assigned formula-fed infants born to women with a peripartum diagnosis of HIV type 1 (HIV-1) infection to one of three regimens: zidovudine for 6 weeks (zidovudine-alone group), zidovudine for 6 weeks plus three doses of nevirapine during the first 8 days of life (two-drug group), or zidovudine for 6 weeks plus nelfinavir and lamivudine for 2 weeks (three-drug group). The primary outcome was HIV-1 infection at 3 months in infants uninfected at birth.
Results: A total of 1684 infants were enrolled in the Americas and South Africa (566 in the zidovudine-alone group, 562 in the two-drug group, and 556 in the three-drug group). The overall rate of in utero transmission of HIV-1 on the basis of Kaplan-Meier estimates was 5.7% (93 infants), with no significant differences among the groups. Intrapartum transmission occurred in 24 infants in the zidovudine-alone group (4.8%; 95% confidence interval [CI], 3.2 to 7.1), as compared with 11 infants in the two-drug group (2.2%; 95% CI, 1.2 to 3.9; P=0.046) and 12 in the three-drug group (2.4%; 95% CI, 1.4 to 4.3; P=0.046). The overall transmission rate was 8.5% (140 infants), with an increased rate in the zidovudine-alone group (P=0.03 for the comparisons with the two- and three-drug groups). On multivariate analysis, zidovudine monotherapy, a higher maternal viral load, and maternal use of illegal substances were significantly associated with transmission. The rate of neutropenia was significantly increased in the three-drug group (P<0.001 for both comparisons with the other groups).
Conclusions: In neonates whose mothers did not receive ART during pregnancy, prophylaxis with a two- or three-drug ART regimen is superior to zidovudine alone for the prevention of intrapartum HIV transmission; the two-drug regimen has less toxicity than the three-drug regimen. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD] and others; ClinicalTrials.gov number, NCT00099359.).
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3590113/bin/nihms396204f1.gif)
Similar articles
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. Cochrane Database Syst Rev. 2011. PMID: 21735394 Review.
-
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.N Engl J Med. 2010 Jun 17;362(24):2271-81. doi: 10.1056/NEJMoa0911486. N Engl J Med. 2010. PMID: 20554982 Free PMC article. Clinical Trial.
-
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Lancet Infect Dis. 2011. PMID: 21237718 Clinical Trial.
-
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003510. doi: 10.1002/14651858.CD003510.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003510. doi: 10.1002/14651858.CD003510.pub3. PMID: 17253490 Updated. Review.
-
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.N Engl J Med. 2004 Jul 15;351(3):217-28. doi: 10.1056/NEJMoa033500. Epub 2004 Jul 9. N Engl J Med. 2004. PMID: 15247338 Clinical Trial.
Cited by
-
Evaluating the impact of triple elimination program for mother-to-child transmission of HIV, syphilis, and hepatitis B in Indonesia.Narra J. 2023 Dec;3(3):e405. doi: 10.52225/narra.v3i3.405. Epub 2023 Nov 17. Narra J. 2023. PMID: 38455604 Free PMC article.
-
Reducing perinatal infection risk in newborns of mothers who received inadequate prenatal care.Paediatr Child Health. 2023 Jul 22;28(5):307-323. doi: 10.1093/pch/pxad014. eCollection 2023 Aug. Paediatr Child Health. 2023. PMID: 37484040 Free PMC article. Review.
-
La réduction du risque d'infection périnatale chez les nouveau-nés de mères dont les soins prénatals étaient inappropriés.Paediatr Child Health. 2023 Jul 22;28(5):307-323. doi: 10.1093/pch/pxad015. eCollection 2023 Aug. Paediatr Child Health. 2023. PMID: 37484035 Free PMC article. Review.
-
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.J Antimicrob Chemother. 2023 Jul 5;78(7):1711-1722. doi: 10.1093/jac/dkad161. J Antimicrob Chemother. 2023. PMID: 37248782 Free PMC article. Clinical Trial.
-
Prevention of the Vertical Transmission of HIV; A Recap of the Journey so Far.Viruses. 2023 Mar 26;15(4):849. doi: 10.3390/v15040849. Viruses. 2023. PMID: 37112830 Free PMC article. Review.
References
-
- Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802. - PubMed
-
- Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171–7. - PubMed
-
- Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202–9. - PubMed
-
- Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005;19:1289–97. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical